1
|
Price G, Devaney S, French DP, Holley R, Holm S, Kontopantelis E, McWilliam A, Payne K, Proudlove N, Sanders C, Willans R, van Staa T, Hamrang L, Turner B, Parsons S, Faivre-Finn C. Can Real-world Data and Rapid Learning Drive Improvements in Lung Cancer Survival? The RAPID-RT Study. Clin Oncol (R Coll Radiol) 2022; 34:407-410. [PMID: 35000827 DOI: 10.1016/j.clon.2021.12.017] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2021] [Revised: 11/29/2021] [Accepted: 12/21/2021] [Indexed: 11/25/2022]
Affiliation(s)
- G Price
- The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, The University of Manchester, The Christie NHS Foundation Trust, Manchester, UK.
| | - S Devaney
- Centre for Social Ethics and Policy, The University of Manchester, Manchester, UK
| | - D P French
- Manchester Centre of Health Psychology, The University of Manchester, Manchester, UK
| | - R Holley
- Division of Cancer Sciences, The University of Manchester, The Christie NHS Foundation Trust, Manchester, UK
| | - S Holm
- Centre for Social Ethics and Policy, The University of Manchester, Manchester, UK
| | - E Kontopantelis
- Centre for Health Services Research, Division of Informatics, Imaging and Data Science, The University of Manchester, Manchester, UK
| | - A McWilliam
- The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, The University of Manchester, The Christie NHS Foundation Trust, Manchester, UK
| | - K Payne
- Manchester Centre for Health Economics, Health Sciences Research Group, The University of Manchester, Manchester, UK
| | - N Proudlove
- Alliance Manchester Business School, The University of Manchester, Manchester, UK
| | - C Sanders
- NIHR Patient Safety Translational Research Centre, The University of Manchester, Manchester, UK
| | - R Willans
- Data Analytics Unit, National Institute for Health and Care Excellence, Manchester, UK
| | - T van Staa
- Centre for Health Informatics & Health Data Research UK North, Division of Informatics, Imaging and Data Science, School of Health Sciences, The University of Manchester, Manchester, UK
| | - L Hamrang
- RAPID-RT PPI Advisory Group, Manchester, UK
| | - B Turner
- RAPID-RT PPI Advisory Group, Manchester, UK
| | | | - C Faivre-Finn
- The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, The University of Manchester, The Christie NHS Foundation Trust, Manchester, UK
| |
Collapse
|
2
|
Averbuch T, Mohamed MO, Islam S, Defilippis EM, Breathett K, Alkhouli MA, Michos ED, Martin GP, Kontopantelis E, Mamas MA, Van Spall HGC. The Association Between Socioeconomic Status, Sex, Race / Ethnicity and In-Hospital Mortality Among Patients Hospitalized for Heart Failure. J Card Fail 2021; 28:697-709. [PMID: 34628014 DOI: 10.1016/j.cardfail.2021.09.012] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2021] [Revised: 09/11/2021] [Accepted: 09/20/2021] [Indexed: 02/07/2023]
Abstract
BACKGROUND The association between socioeconomic status (SES), sex, race / ethnicity and outcomes during hospitalization for heart failure (HF) has not previously been investigated. METHODS AND RESULTS We analyzed HF hospitalizations in the United States National Inpatient Sample between 2015 and 2017. Using a hierarchical, multivariable Poisson regression model to adjust for hospital- and patient-level factors, we assessed the association between SES, sex, and race / ethnicity and all-cause in-hospital mortality. We estimated the direct costs (USD) across SES groups. Among 4,287,478 HF hospitalizations, 40.8% were in high SES, 48.7% in female, and 70.0% in White patients. Relative to these comparators, low SES (homelessness or lowest quartile of median neighborhood income) (relative risk [RR] 1.02, 95% confidence interval [CI] 1.00-1.05) and male sex (RR 1.09, 95% CI 1.07-1.11) were associated with increased risk, whereas Black (RR 0.79, 95% CI 0.76-0.81) and Hispanic (RR 0.90, 95% CI 0.86-0.93) race / ethnicity were associated with a decreased risk of in-hospital mortality (5.1% of all hospitalizations). There were significant interactions between race / ethnicity and both, SES (P < .01) and sex (P = .04), such that racial/ethnic differences in outcome were more pronounced in low SES groups and in male patients. The median direct cost of admission was lower in low vs high SES groups ($9324.60 vs $10,940.40), female vs male patients ($9866.60 vs $10,217.10), and Black vs White patients ($9077.20 vs $10,019.80). The median costs increased with SES in all demographic groups primarily related to greater procedural utilization. CONCLUSIONS SES, sex, and race / ethnicity were independently associated with in-hospital mortality during HF hospitalization, highlighting possible care disparities. Racial/ethnic differences in outcome were more pronounced in low SES groups and in male patients.
Collapse
Affiliation(s)
- T Averbuch
- Department of Medicine, McMaster University, Hamilton, Ontario, Canada
| | - M O Mohamed
- Department of Cardiology, Keele University, Keele, UK
| | - S Islam
- Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada; Division of Biostatistics, Population Health Research Institute, Hamilton, Ontario, Canada
| | - E M Defilippis
- Department of Cardiology, Columbia University, New York, New York
| | - K Breathett
- Department of Medicine, University of Arizona, Tucson, Arizona
| | - M A Alkhouli
- Department of Cardiovascular Disease, Mayo Clinic, Rochester, New York
| | - E D Michos
- Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland
| | - G P Martin
- Division of Informatics, Imaging and Data Science, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
| | - E Kontopantelis
- Division of Informatics, Imaging and Data Science, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
| | - M A Mamas
- Department of Cardiology, Keele University, Keele, UK
| | - H G C Van Spall
- Department of Medicine, McMaster University, Hamilton, Ontario, Canada; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada; Population Health Research Institute, Hamilton, Ontario, Canada.
| |
Collapse
|
3
|
Kwok CS, Achenbach S, Curzen N, Fischman DL, Savage M, Bagur R, Kontopantelis E, Martin G, Steg PG, Mamas MA. P6510Frailty and in-hospital outcomes in percutaneous coronary interventions. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz746.1100] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Frailty may be an important marker for poor outcomes in percutaneous coronary intervention (PCI) and there is limited literature on outcomes based on frailty from national cohorts.
Purpose
This study evaluates the prevalence of frailty, changes in frailty over time and outcomes associated with frailty in a national American cohort of patients who underwent PCI.
Methods
The study included adults who underwent PCI in the National Inpatients Sample between 2004 and 2014. Frailty risk was determined using a validated Hospital Frailty Risk Score (HFRS) using the cutoffs <5, 5–15 and >15 corresponding to low, intermediate and high HFRS.
Results
There were 7,306,007 PCI admissions in this cohort. A total of 94.58%, 5.39% and 0.03% of admissions were for low HFRS, intermediate HFRS and high HFRS, respectively. The proportion of intermediate or high frailty risk patients increased over time from 1.9% in 2004 to 11.7% in 2014. In-hospital death increased from 1.0% with low HFRS to 13.9% with high HFRS and average length of stay increased from 2.9±3.3 days to 17.1±15.5 days from low to high HFRS. Greater frailty risk was associated with greater average inpatient cost which was $17,743±11,059, $38,824±34,809 and $56,119±49,772 for low, intermediate and high HFRS, respectively. There were increased adverse outcomes with high frailty including greater in-hospital death (OR 9.91 95% CI 7.17–13.71), in-hospital bleeding complications (OR 4.99 95% CI 3.82–6.51), in-hospital vascular complications (OR 3.96 95% CI 3.00–5.23) and in-hospital stroke (OR 10.49 95% CI 8.28–13.29) comparing high to low HFRS.
Conclusions
More than 1 in 20 patients who undergo PCI have intermediate or high risk of frailty which has significantly increased over time. There are poor outcomes and increased inpatient costs associated with greater frailty. Improvements in education of healthcare workers and increased awareness of frailty could facilitate frailty-tailored care to minimise risk of adverse outcomes and its associated costs.
Acknowledgement/Funding
Research and Development Department at the Royal Stoke Hospital, Keele University and Biosensors International
Collapse
Affiliation(s)
- C S Kwok
- University Hospital of North Staffordshire, Stoke On Trent, United Kingdom
| | - S Achenbach
- Friedrich Alexander University, Department of Cardiology, Erlangen, Germany
| | - N Curzen
- University Hospital Southampton NHS Foundation Trust, Department of Cardiology, Southampton, United Kingdom
| | - D L Fischman
- Thomas Jefferson University Hospital, Department of Medicine (Cardiology), Philadelphia, United States of America
| | - M Savage
- Thomas Jefferson University Hospital, Department of Medicine (Cardiology), Philadelphia, United States of America
| | - R Bagur
- Keele University, Keele Cardiovascular Research Group, Stoke-on-Trent, United Kingdom
| | - E Kontopantelis
- University of Manchester, Division of Informatics, Imaging and Data Science, Faculty of Biology, Medicine and Health, Manchester, United Kingdom
| | - G Martin
- University of Manchester, Division of Informatics, Imaging and Data Science, Faculty of Biology, Medicine and Health, Manchester, United Kingdom
| | - P G Steg
- National Institute of Health and Medical Research (INSERM home), INSERM U-1148, all in Paris, France; Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - M A Mamas
- Keele University, Keele Cardiovascular Research Group, Stoke-on-Trent, United Kingdom
| |
Collapse
|
4
|
Zghebi SS, Panagioti M, Rutter MK, Ashcroft DM, van Marwijk H, Salisbury C, Chew-Graham CA, Buchan I, Qureshi N, Peek N, Mallen C, Mamas M, Kontopantelis E. Assessing the severity of Type 2 diabetes using clinical data-based measures: a systematic review. Diabet Med 2019; 36:688-701. [PMID: 30672017 DOI: 10.1111/dme.13905] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 01/21/2019] [Indexed: 01/11/2023]
Abstract
AIMS To identify and critically appraise measures that use clinical data to grade the severity of Type 2 diabetes. METHODS We searched MEDLINE, Embase and PubMed between inception and June 2018. Studies reporting on clinical data-based diabetes-specific severity measures in adults with Type 2 diabetes were included. We excluded studies conducted solely in participants with other types of diabetes. After independent screening, the characteristics of the eligible measures including design and severity domains, the clinical utility of developed measures, and the relationship between severity levels and health-related outcomes were assessed. RESULTS We identified 6798 studies, of which 17 studies reporting 18 different severity measures (32 314 participants in 17 countries) were included: a diabetes severity index (eight studies, 44%); severity categories (seven studies, 39%); complication count (two studies, 11%); and a severity checklist (one study, 6%). Nearly 89% of the measures included diabetes-related complications and/or glycaemic control indicators. Two of the severity measures were validated in a separate study population. More severe diabetes was associated with increased healthcare costs, poorer cognitive function and significantly greater risks of hospitalization and mortality. The identified measures differed greatly in terms of the included domains. One study reported on the use of a severity measure prospectively. CONCLUSIONS Health records are suitable for assessment of diabetes severity; however, the clinical uptake of existing measures is limited. The need to advance this research area is fundamental as higher levels of diabetes severity are associated with greater risks of adverse outcomes. Diabetes severity assessment could help identify people requiring targeted and intensive therapies and provide a major benchmark for efficient healthcare services.
Collapse
Affiliation(s)
- S S Zghebi
- Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre (MAHSC), University of Manchester, Manchester
- NIHR School for Primary Care Research, Centre for Primary Care, Manchester Academic Health Science Centre (MAHSC), University of Manchester, Manchester
| | - M Panagioti
- Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre (MAHSC), University of Manchester, Manchester
- NIHR School for Primary Care Research, Centre for Primary Care, Manchester Academic Health Science Centre (MAHSC), University of Manchester, Manchester
| | - M K Rutter
- Division of Diabetes, Endocrinology and Gastroenterology, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre (MAHSC), University of Manchester, Manchester
- Manchester Diabetes Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre (MAHSC), Manchester, Manchester
| | - D M Ashcroft
- NIHR School for Primary Care Research, Centre for Primary Care, Manchester Academic Health Science Centre (MAHSC), University of Manchester, Manchester
- Centre for Pharmacoepidemiology and Drug Safety, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre (MAHSC), University of Manchester, Manchester
| | - H van Marwijk
- Division of Primary Care and Public Health, Brighton and Sussex Medical School, University of Brighton, Brighton
| | - C Salisbury
- Centre for Academic Primary Care, Department of Population Health Sciences, Bristol Medical School, Bristol
| | - C A Chew-Graham
- Research Institute for Primary Care and Health Sciences, Keele University, Staffordshire
| | - I Buchan
- Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre (MAHSC), University of Manchester, Manchester
- Health eResearch Centre, Division of Informatics, Imaging and Data Science, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester
- Department of Public Health and Policy, Institute of Population Health Sciences, University of Liverpool, Liverpool
| | - N Qureshi
- Primary Care Stratified Medicine (PriSM) group, Division of Primary Care, School of Medicine, University of Nottingham, Nottingham
| | - N Peek
- Health eResearch Centre, Division of Informatics, Imaging and Data Science, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester
| | - C Mallen
- Research Institute for Primary Care and Health Sciences, Keele University, Staffordshire
| | - M Mamas
- Keele Cardiovascular Research group, Centre for Prognosis Research, Institute for Primary Care and Health Sciences, Keele University, Stoke-on-Trent, UK
| | - E Kontopantelis
- Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre (MAHSC), University of Manchester, Manchester
- NIHR School for Primary Care Research, Centre for Primary Care, Manchester Academic Health Science Centre (MAHSC), University of Manchester, Manchester
| |
Collapse
|
5
|
Heal CF, Banks JL, Lepper P, Kontopantelis E, van Driel ML. Meta-analysis of randomized and quasi-randomized clinical trials of topical antibiotics after primary closure for the prevention of surgical-site infection. Br J Surg 2017; 104:1123-1130. [PMID: 28656693 DOI: 10.1002/bjs.10588] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2016] [Revised: 02/23/2017] [Accepted: 04/06/2017] [Indexed: 11/07/2022]
Abstract
BACKGROUND Surgical-site infections (SSIs) increase patient morbidity and costs. The aim was to identify and synthesize all RCTs evaluating the effect of topical antibiotics on SSI in wounds healing by primary intention. METHODS The search included Ovid MEDLINE, Ovid Embase, the Cochrane Wounds Specialized Register, Central Register of Controlled Trials and EBSCO CINAHL from inception to May 2016. There was no restriction of language, date or setting. Two authors independently selected studies, extracted data and assessed risk of bias. When sufficient numbers of comparable trials were available, data were pooled in meta-analysis. RESULTS Fourteen RCTs with 6466 participants met the inclusion criteria. Pooling of eight trials (5427 participants) showed that topical antibiotics probably reduced the risk of SSI compared with no topical antibiotic (risk ratio (RR) 0·61, 95 per cent c.i. 0·42 to 0·87; moderate-quality evidence), equating to 20 fewer SSIs per 1000 patients treated. Pooling of three trials (3012 participants) for risk of allergic contact dermatitis found no clear difference between antibiotics and no antibiotic (RR 3·94, 0·46 to 34·00; very low-quality evidence). Pooling of five trials (1299 participants) indicated that topical antibiotics probably reduce the risk of SSI compared with topical antiseptics (RR 0·49, 0·30 to 0·80; moderate-quality evidence); 43 fewer SSIs per 1000 patients treated. Pooling of two trials (541 participants) showed no clear difference in the risk of allergic contact dermatitis with antibiotics or antiseptic agents (RR 0·97, 0·52 to 1·82; very low-quality evidence). CONCLUSION Topical antibiotics probably prevent SSI compared with no topical antibiotic or antiseptic. No conclusion can be drawn regarding whether they cause allergic contact dermatitis.
Collapse
Affiliation(s)
- C F Heal
- Department of General Practice and Rural Medicine, James Cook University, Mackay, Queensland, Australia
- College of Medicine and Dentistry, James Cook University, Mackay, Queensland, Australia
- Mackay Institute of Research and Innovation, James Cook University, Mackay, Queensland, Australia
| | - J L Banks
- College of Medicine and Dentistry, James Cook University, Mackay, Queensland, Australia
| | - P Lepper
- College of Medicine and Dentistry, James Cook University, Mackay, Queensland, Australia
| | - E Kontopantelis
- Centre for Health Informatics, Institute of Population Health, University of Manchester, Manchester, UK
| | - M L van Driel
- Discipline of General Practice, School of Medicine, University of Queensland, Brisbane, Queensland, Australia
| |
Collapse
|
6
|
Springate DA, Parisi R, Kontopantelis E, Reeves D, Griffiths CEM, Ashcroft DM. Incidence, prevalence and mortality of patients with psoriasis: a U.K. population-based cohort study. Br J Dermatol 2016; 176:650-658. [PMID: 27579733 PMCID: PMC5363241 DOI: 10.1111/bjd.15021] [Citation(s) in RCA: 137] [Impact Index Per Article: 17.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/22/2016] [Indexed: 02/03/2023]
Abstract
BACKGROUND The burden of psoriasis across many world regions is high and there is a recognized need to better understand the epidemiology of this common skin disorder. OBJECTIVES To examine changes in the prevalence and incidence of psoriasis, and mortality rates over a 15-year period. METHODS Cohort study involving analysis of longitudinal electronic health records between 1999 and 2013 using the U.K. Clinical Practice Research Datalink (CPRD). RESULTS The prevalence of psoriasis increased steadily from 2·3% (2297 cases per 100 000) in 1999 to 2·8% (2815 per 100 000) in 2013, which does not appear to be attributable to changes in incidence rates. We observed peaks in age bands characteristic of early-onset (type I) and late-onset (type II) psoriasis, and changes in incidence and prevalence rates with increasing latitude in the U.K. All-cause mortality rates for the general population and for patients with psoriasis have decreased over the last 15 years. However, the risk of all-cause mortality for patients with psoriasis remains elevated compared with people without psoriasis (hazard ratio 1·21; 95% confidence interval 1·13-1·3) and we found no significant change in this relative excess mortality gap over time. CONCLUSIONS We found an increasing population living longer with psoriasis in the U.K., which has important implications for healthcare service delivery and for resource allocation. Importantly, early mortality in patients with psoriasis remains elevated compared with the general population and we found no evidence of change in this premature mortality gap.
Collapse
Affiliation(s)
- D A Springate
- NIHR School for Primary Care Research (Centre for Primary Care), University of Manchester, Stopford Building, Oxford Road, Manchester, M13 9PT, U.K.,Centre for Biostatistics, University of Manchester, Stopford Building, Oxford Road, Manchester, M13 9PT, U.K
| | - R Parisi
- Centre for Pharmacoepidemiology and Drug Safety, Manchester Pharmacy School, University of Manchester, Stopford Building, Oxford Road, Manchester, M13 9PT, U.K
| | - E Kontopantelis
- NIHR School for Primary Care Research (Centre for Primary Care), University of Manchester, Stopford Building, Oxford Road, Manchester, M13 9PT, U.K.,Centre for Health Informatics, Institute of Population Health, University of Manchester, Stopford Building, Oxford Road, Manchester, M13 9PT, U.K
| | - D Reeves
- NIHR School for Primary Care Research (Centre for Primary Care), University of Manchester, Stopford Building, Oxford Road, Manchester, M13 9PT, U.K.,Centre for Biostatistics, University of Manchester, Stopford Building, Oxford Road, Manchester, M13 9PT, U.K
| | - C E M Griffiths
- Dermatology Centre, Salford Royal NHS Foundation Trust, University of Manchester, Manchester Academic Health Science Centre, Manchester, U.K
| | - D M Ashcroft
- NIHR School for Primary Care Research (Centre for Primary Care), University of Manchester, Stopford Building, Oxford Road, Manchester, M13 9PT, U.K.,Centre for Pharmacoepidemiology and Drug Safety, Manchester Pharmacy School, University of Manchester, Stopford Building, Oxford Road, Manchester, M13 9PT, U.K
| |
Collapse
|
7
|
Windfuhr K, While D, Kapur N, Ashcroft DM, Kontopantelis E, Carr MJ, Shaw J, Appleby L, Webb RT. Suicide risk linked with clinical consultation frequency, psychiatric diagnoses and psychotropic medication prescribing in a national study of primary-care patients. Psychol Med 2016; 46:3407-3417. [PMID: 27650367 DOI: 10.1017/s0033291716001823] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
BACKGROUND Little is known about the precursors of suicide risk among primary-care patients. This study aimed to examine suicide risk in relation to patterns of clinical consultation, psychotropic drug prescribing, and psychiatric diagnoses. METHOD Nested case-control study in the Clinical Practice Research Datalink (CPRD), England. Patients aged ⩾16 years who died by suicide during 2002-2011 (N = 2384) were matched on gender, age and practice with up to 20 living control patients (N = 46 899). RESULTS Risk was raised among non-consulting patients, and increased sharply with rising number of consultations in the preceding year [⩾12 consultations v. 1: unadjusted odds ratio (OR) 6.0, 95% confidence interval (CI) 4.9-7.3]. Markedly elevated risk was also associated with the prescribing of multiple psychotropic medication types (⩾5 types v. 0: OR 62.6, CI 44.3-88.4) and with having several psychiatric diagnoses (⩾4 diagnoses v. 0: OR 31.1, CI 19.3-50.1). Risk was also raised among patients living in more socially deprived localities. The confounding effect of multiple psychotropic drug types largely accounted for the rising risk gradient observed with increasing consultation frequency. CONCLUSIONS A greater proportion of patients with several psychiatric diagnoses, those prescribed multiple psychotropic medication types, and those who consult at very high frequency might be considered for referral to mental health services by their general practitioners. Non-consulters are also at increased risk, which suggests that conventional models of primary care may not be effective in meeting the needs of all people in the community experiencing major psychosocial difficulties.
Collapse
Affiliation(s)
- K Windfuhr
- National Confidential Inquiry into Suicide and Homicide by People with Mental Illness,University of Manchester,UK
| | - D While
- National Confidential Inquiry into Suicide and Homicide by People with Mental Illness,University of Manchester,UK
| | - N Kapur
- National Confidential Inquiry into Suicide and Homicide by People with Mental Illness,University of Manchester,UK
| | - D M Ashcroft
- Centre for Pharmacoepidemiology and Drug Safety,Manchester Pharmacy School and NIHR Greater Manchester Primary Care Patient Safety Translational Research Centre,University of Manchester,UK
| | - E Kontopantelis
- Centre for Health Informatics,Institute of Population Health,University of Manchester,UK
| | - M J Carr
- Centre for Mental Health and Safety,University of Manchester,UK
| | - J Shaw
- National Confidential Inquiry into Suicide and Homicide by People with Mental Illness,University of Manchester,UK
| | - L Appleby
- National Confidential Inquiry into Suicide and Homicide by People with Mental Illness,University of Manchester,UK
| | - R T Webb
- Centre for Mental Health and Safety,University of Manchester,UK
| |
Collapse
|
8
|
Kwok CS, Aslam S, Kontopantelis E, Myint PK, Zaman MJS, Buchan I, Loke YK, Mamas MA. Influenza, influenza-like symptoms and their association with cardiovascular risks: a systematic review and meta-analysis of observational studies. Int J Clin Pract 2015; 69:928-37. [PMID: 25940136 PMCID: PMC7165588 DOI: 10.1111/ijcp.12646] [Citation(s) in RCA: 35] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
Abstract
AIMS To synthesise the evidence relating influenza and influenza-like symptoms to the risks of myocardial infarction (MI), heart failure (HF) and stroke. METHODS We conducted a systematic review and meta-analysis of the evidence relating influenza and influenza-like symptoms to the risks of MI, HF and stroke. We systematically searched all MEDLINE and EMBASE entries up to August 2014 for studies of influenza vs. the cardiovascular outcomes above. We conducted random effects meta-analysis using inverse variance method for pooled odds ratios (OR) and evaluated statistical heterogeneity using the I(2) statistic. RESULTS We identified 12 studies with a total of 84,003 participants. The pooled OR for risk of MI vs. influenza (serologically confirmed) was 1.27 (95% CI, confidence interval 0.54-2.95), I(2) = 47%, which was significant for the only study that adjusted for confounders (OR 5.50, 95% CI 1.31-23.13). The pooled OR for risk of MI vs. influenza-like symptoms was 2.17 (95% CI 1.68-2.80), I(2) = 0%, which was significant for both unadjusted (OR 2.23, 95% CI 1.65-3.01, five studies) and adjusted studies (OR 2.01, 95% CI 1.24-3.27, two studies). We found one study that evaluated stroke risk, one study in patients with HF, and one that evaluated mortality from MI - all of these studies suggested increased risks of events with influenza-like symptoms. CONCLUSIONS There is an association between influenza-like illness and cardiovascular events, but the relationship is less clear with serologically diagnosed influenza. We recommend renewed efforts to apply current clinical guidelines and maximise the uptake of annual influenza immunisation among patients with cardiovascular diseases, to decrease their risks of MI and stroke.
Collapse
Affiliation(s)
- C S Kwok
- Cardiovascular Research Group, Institute of Cardiovascular Sciences, University of Manchester, Manchester, UK
| | - S Aslam
- Central Manchester Foundation Trust, Manchester, UK
| | - E Kontopantelis
- Centre for Health Informatics, Institute of Population Health, University of Manchester, Manchester, UK
| | - P K Myint
- Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK
| | - M J S Zaman
- Department of Cardiology, James Paget University Hospital, Gorleston-on-Sea, UK
| | - I Buchan
- Centre for Health Informatics, Institute of Population Health, University of Manchester, Manchester, UK
| | - Y K Loke
- Norwich Medical School, University of East Anglia, Norwich, UK
| | - M A Mamas
- Cardiovascular Research Group, Institute of Cardiovascular Sciences, University of Manchester, Manchester, UK
- Keele Cardiovascular Research Group, University of Keele, Stoke-on-Trent, UK
| |
Collapse
|
9
|
Stocks SJ, Kontopantelis E, Akbarov A, Avery AJ, Ashcroft DA. OP57 Examining prescribing safety in UK general practice: a cross-sectional study using the clinical practice research database. Br J Soc Med 2015. [DOI: 10.1136/jech-2015-206256.56] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
10
|
Molassiotis A, Stamataki Z, Kontopantelis E. Development and preliminary validation of a risk prediction model for chemotherapy-related nausea and vomiting. Support Care Cancer 2013; 21:2759-67. [PMID: 23715816 DOI: 10.1007/s00520-013-1843-2] [Citation(s) in RCA: 49] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2012] [Accepted: 05/07/2013] [Indexed: 11/26/2022]
Abstract
BACKGROUND A number of risk factors have been implicated in the development of chemotherapy-induced nausea/vomiting (CINV). Our aim was to develop a risk prediction model and identify patients at high risk for developing CINV before their chemotherapy treatment. PATIENTS AND METHODS A multisite, observational, prospective longitudinal design was used. Participants were 336 chemotherapy-naïve cancer patients providing 791 assessments. They completed measures to assess potential risk factors for CINV, including socio-demographic and clinical/treatment-related characteristics, symptom distress, expectations for CINV and state-trait anxiety. CINV was measured with the MASCC Antiemesis Tool. Participants were divided randomly to a training set (=286) and a test set (=50). Random-effects models were run to ascertain the contribution of risk factors in the development of CINV using the training sample. Specificity and sensitivity of the model were assessed in both sets of samples. RESULTS Younger age, history of nausea/vomiting, trait anxiety and fatigue were linked with higher levels of CINV, and use of moderately and low emetogenic chemotherapy were linked with lower CINV. The model's specificity were 55.4 and 50.0 % and sensitivity were 80.3 and 79.0 % in the training and test sample, respectively. A dynamic web-based tool is freely available for use by clinicians. CONCLUSION This model of risk prediction for CINV can be an aid to clinical decision-making and assist clinicians to rationalise antiemetic use with their patients.
Collapse
Affiliation(s)
- A Molassiotis
- School of Nursing, Midwifery & Social Work, University of Manchester, Manchester, UK,
| | | | | |
Collapse
|
11
|
Heussinger N, Kontopantelis E, Rompel O, Paulides M, Trollmann R. Predicting multiple sclerosis following isolated optic neuritis in children. Eur J Neurol 2013; 20:1292-6. [DOI: 10.1111/ene.12184] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2012] [Accepted: 03/25/2013] [Indexed: 11/30/2022]
Affiliation(s)
- N. Heussinger
- Department of Pediatrics; University Clinic of Erlangen-Nuremberg; Erlangen Germany
| | - E. Kontopantelis
- Institute of Population Health; University of Manchester; Manchester UK
| | - O. Rompel
- Department of Radiology; University Clinic of Erlangen-Nuremberg; Erlangen Germany
| | - M. Paulides
- Department of Pediatrics; University Clinic of Erlangen-Nuremberg; Erlangen Germany
| | - R. Trollmann
- Department of Pediatrics; University Clinic of Erlangen-Nuremberg; Erlangen Germany
| |
Collapse
|
12
|
Stamataki Z, Molassiotis A, Kontopantelis E. 75 A Risk Prediction Model of Chemotherapy Related Nausea and Vomiting. Eur J Oncol Nurs 2012. [DOI: 10.1016/s1462-3889(12)70089-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
13
|
Chauhan U, Kontopantelis E, Campbell S, Jarrett H, Lester H. Health checks in primary care for adults with intellectual disabilities: how extensive should they be? J Intellect Disabil Res 2010; 54:479-486. [PMID: 20576060 DOI: 10.1111/j.1365-2788.2010.01263.x] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
Abstract
BACKGROUND Routine health checks have gained prominence as a way of detecting unmet need in primary care for adults with intellectual disabilities (ID) and general practitioners are being incentivised in the UK to carry out health checks for many conditions through an incentivisation scheme known as the Quality and Outcomes Framework (QOF). However, little is known about the data being routinely recorded in such health checks in relation to people with ID as practices are currently only incentivised to keep a register of people with ID. The aim of this study was to explore the additional value of a health check for people with ID compared with standard care provided through the current QOF structure. METHODS Representative practices were recruited using a stratified sampling approach in four primary care trusts to carry out health checks over a 6-month period. The extracted data were divided into two aggregated informational domains for the purpose of multilevel regression analysis: 'ID-specific' (containing data on visual assessment, hearing assessment, behaviour assessment, bladder function, bowel function and feeding assessment) and financially incentivised QOF targets (blood pressure, smoking status, ethnicity, body mass index, urine analysis and carer details) which are incentivised processes. RESULTS A total of 651 patients with ID were identified in 27 practices. Only nine practices undertook a health check on 92 of their patients with ID. Significant differences were found in the recorded information, between those who underwent a health check and those who did not (P < 0.001, chi(2) = 56.3). In the group that had health check, recorded information was on average higher for the 'QOF targets' domain, compared with the 'ID-specific' domain, by 58.7% (95% CI: 54.1, 63.3, P < 0.001). CONCLUSIONS If incentives are to be used as a method for improving care for people with ID through health checks a more targeted approach focused on ID-specific health issues might be more appropriate than an extensive health check.
Collapse
Affiliation(s)
- U Chauhan
- University of Manchester, National Primary Care Research and Development Centre, Manchester, UK.
| | | | | | | | | |
Collapse
|
14
|
Papageorgiou C, Kontaxakis VP, Havaki-Kontaxaki BJ, Stamouli S, Vasios C, Asvestas P, Matsopoulos GK, Kontopantelis E, Rabavilas A, Uzunoglu N, Christodoulou GN. Impaired P600 in neuroleptic naive patients with first-episode schizophrenia. Neuroreport 2001; 12:2801-6. [PMID: 11588580 DOI: 10.1097/00001756-200109170-00010] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
Deficits of working memory (WM) are recognized as an important pathological feature in schizophrenia. Since the P600 component of event related potentials has been hypothesized that represents aspects of second-pass parsing processes of information processing, and is related to WM, the present study focuses on P600 elicited during a WM test in drug-naive first-episode schizophrenics (FES) compared to healthy controls. We examined 16 drug-naive first-episode schizophrenic patients and 23 healthy controls matched for age and sex. Compared with controls schizophrenic patients showed reduced P600 amplitude on left temporoparietal region and increased P600 amplitude on left occipital region. With regard to the latency, the patients exhibited significantly prolongation on right temporoparietal region. The obtained pattern of differences classified correctly 89.20% of patients. Memory performance of patients was also significantly impaired relative to controls. Our results suggest that second-pass parsing process of information processing, as indexed by P600, elicited during a WM test, is impaired in FES. Moreover, these findings lend support to the view that the auditory WM in schizophrenia involves or affects a circuitry including temporoparietal and occipital brain areas.
Collapse
Affiliation(s)
- C Papageorgiou
- Department of Psychiatry, Eginition Hospital, 74 Vas. Sophias Ave., Athens 11528, Greece
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|